190 related articles for article (PubMed ID: 22266911)
1. 5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype.
Castro FV; McGinn OJ; Krishnan S; Marinov G; Li J; Rutkowski AJ; Elkord E; Burt DJ; Holland M; Vaghjiani R; Gallego A; Saha V; Stern PL
Leukemia; 2012 Jul; 26(7):1487-98. PubMed ID: 22266911
[TBL] [Abstract][Full Text] [Related]
2. CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling.
Arnaud MP; Vallée A; Robert G; Bonneau J; Leroy C; Varin-Blank N; Rio AG; Troadec MB; Galibert MD; Gandemer V
Blood; 2015 Oct; 126(15):1802-12. PubMed ID: 26320102
[TBL] [Abstract][Full Text] [Related]
3. Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia.
McGinn OJ; Krishnan S; Bourquin JP; Sapra P; Dempsey C; Saha V; Stern PL
Haematologica; 2017 Jun; 102(6):1075-1084. PubMed ID: 28341731
[TBL] [Abstract][Full Text] [Related]
4. IL7R is associated with CNS infiltration and relapse in pediatric B-cell precursor acute lymphoblastic leukemia.
Alsadeq A; Lenk L; Vadakumchery A; Cousins A; Vokuhl C; Khadour A; Vogiatzi F; Seyfried F; Meyer LH; Cario G; Hobeika E; Debatin KM; Halsey C; Schrappe M; Schewe DM; Jumaa H
Blood; 2018 Oct; 132(15):1614-1617. PubMed ID: 30154115
[No Abstract] [Full Text] [Related]
5. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
[TBL] [Abstract][Full Text] [Related]
6. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Uckun FM; Downing JR; Gunther R; Chelstrom LM; Finnegan D; Land VJ; Borowitz MJ; Carroll AJ; Crist WM
Blood; 1993 Jun; 81(11):3052-62. PubMed ID: 8098968
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model.
Canale S; Cocco C; Frasson C; Seganfreddo E; Di Carlo E; Ognio E; Sorrentino C; Ribatti D; Zorzoli A; Basso G; Dufour C; Airoldi I
Leukemia; 2011 Dec; 25(12):1815-24. PubMed ID: 21701492
[TBL] [Abstract][Full Text] [Related]
8. 5T4 oncofetal antigen in gastric carcinoma and its clinical significance.
Starzynska T; Wiechowska-Kozlowska A; Marlicz K; Bromley M; Roberts SA; Lawniczak M; Kolodziej B; Zyluk A; Stern PL
Eur J Gastroenterol Hepatol; 1998 Jun; 10(6):479-84. PubMed ID: 9855063
[TBL] [Abstract][Full Text] [Related]
9. RAC2, AEP, and ICAM1 expression are associated with CNS disease in a mouse model of pre-B childhood acute lymphoblastic leukemia.
Holland M; Castro FV; Alexander S; Smith D; Liu J; Walker M; Bitton D; Mulryan K; Ashton G; Blaylock M; Bagley S; Connolly Y; Bridgeman J; Miller C; Krishnan S; Dempsey C; Masurekar A; Stern P; Whetton A; Saha V
Blood; 2011 Jul; 118(3):638-49. PubMed ID: 21606482
[TBL] [Abstract][Full Text] [Related]
10. Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant.
Shand JC; Jansson J; Hsu YC; Campbell A; Mullen CA
Cancer Immunol Immunother; 2010 Nov; 59(11):1633-44. PubMed ID: 20602231
[TBL] [Abstract][Full Text] [Related]
11. The BCL-2 protein in precursor B acute lymphoblastic leukemia in children.
Chaber R; Fiszer-Maliszewska L; Noworolska-Sauren D; Kwasnicka J; Wrobel G; Chybicka A
J Pediatr Hematol Oncol; 2013 Apr; 35(3):180-7. PubMed ID: 23511489
[TBL] [Abstract][Full Text] [Related]
12. The induction of CD10 on a pre-B leukemia cell line occurs with progression of the disease in scid mice.
Ishii E; Greaves A; Grunberger T; Freedman MH; Letarte M
Leukemia; 1993 Oct; 7(10):1592-601. PubMed ID: 7692193
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion.
Berthier-Vergnes O; El Kharbili M; de la Fouchardière A; Pointecouteau T; Verrando P; Wierinckx A; Lachuer J; Le Naour F; Lamartine J
Br J Cancer; 2011 Jan; 104(1):155-65. PubMed ID: 21081927
[TBL] [Abstract][Full Text] [Related]
14. Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.
Hsieh YT; Gang EJ; Geng H; Park E; Huantes S; Chudziak D; Dauber K; Schaefer P; Scharman C; Shimada H; Shojaee S; Klemm L; Parameswaran R; Loh M; Kang ES; Koo HH; Hofmann WK; Andrade J; Crooks GM; Willman CL; Müschen M; Papayannopoulou T; Heisterkamp N; Bönig H; Kim YM
Blood; 2013 Mar; 121(10):1814-8. PubMed ID: 23319569
[TBL] [Abstract][Full Text] [Related]
15. Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice.
Kamel-Reid S; Dick JE; Greaves A; Murdoch B; Doedens M; Grunberger T; Thorner P; Freedman MH; Phillips RA; Letarte M
Leukemia; 1992 Jan; 6(1):8-17. PubMed ID: 1531243
[TBL] [Abstract][Full Text] [Related]
16. VLA-4 is involved in the engraftment of the human pre-B acute lymphoblastic leukaemia cell line NALM-6 in SCID mice.
Filshie R; Gottlieb D; Bradstock K
Br J Haematol; 1998 Sep; 102(5):1292-300. PubMed ID: 9753059
[TBL] [Abstract][Full Text] [Related]
17. CD11b is a therapy resistance- and minimal residual disease-specific marker in precursor B-cell acute lymphoblastic leukemia.
Rhein P; Mitlohner R; Basso G; Gaipa G; Dworzak MN; Kirschner-Schwabe R; Hagemeier C; Stanulla M; Schrappe M; Ludwig WD; Karawajew L; Ratei R
Blood; 2010 May; 115(18):3763-71. PubMed ID: 20228269
[TBL] [Abstract][Full Text] [Related]
18. Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients.
Servais EL; Colovos C; Rodriguez L; Bograd AJ; Nitadori J; Sima C; Rusch VW; Sadelain M; Adusumilli PS
Clin Cancer Res; 2012 May; 18(9):2478-89. PubMed ID: 22371455
[TBL] [Abstract][Full Text] [Related]
19. Protumoral role of monocytes in human B-cell precursor acute lymphoblastic leukemia: involvement of the chemokine CXCL10.
Lee Y; Chittezhath M; André V; Zhao H; Poidinger M; Biondi A; D'Amico G; Biswas SK
Blood; 2012 Jan; 119(1):227-37. PubMed ID: 22058116
[TBL] [Abstract][Full Text] [Related]
20. EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.
Matsuda T; Takeuchi H; Matsuda S; Hiraiwa K; Miyasho T; Okamoto M; Kawasako K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S356-64. PubMed ID: 24566863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
